To the editor: Transplantation-associated thrombotic microangiopathy (TA-TMA) is characterized by endothelial dysfunction, microthrombi formation and complement activation, frequently resulting in multiorgan dysfunction syndrome (MODS) and mortality [1]. No standardized guidelines or approved treatment exist for TA-TMA.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Shawn P.
Contact Shawn P., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack